Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dan'ge Fentong Capsules for diabetic peripheral neuropathy (Yin deficiency and blood stasis pattern)
CTR20211001Phase 2Completed
- Sponsor
- Sichuan Academy of Chinese Medical Sciences
- Start
- May 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing Dan'ge Fentong Capsules with Placebo (Stimulant Capsules comparator) (2 arms). Primary endpoint: Change in Toronto Clinical Scoring System (TCSS) total score from baseline to week 16. Started May 2021; status: completed.
02
Drugs
Dan'ge Fentong Capsules
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20211001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211001.